Hospital Management Healthcare Companies Primary Care Pharmacy Services Clinical Research Pharmaceuticals Medical Equipment Hospice Care Surgical Facilities Specialty Pharmacy BPO Services Global Operations Healthcare Education Corporate Governance Healthcare Workforce Financial Mismanagement Healthcare Segments COVID-19 Insurance Services Primary Care Clinics EasyHealth Patient Care Electronic Payment Systems Connectivity Testing Homecare Health Services Clinic Closure Accountable Care Organizations Value-Based Care Laboratory Services Pharmacy Operations Hospitals Diagnostic Services Revenue Growth Pharmacy Diagnostic Imaging Healthcare Operations Skilled Nursing Facilities Hospital Administration Oncology Nursing Care Corporate Acquisitions Out-of-Network Billing Telehealth Dialysis Care Diagnostics Market Trends Specialty Services Operational Efficiency Emergency Relief Funding Payer Services Max Healthcare Institute Labor Relations Multi-Speciality Hospitals Health Solutions Health Insurance Pharmacy Care Sterilization Services Health Care Companies Fraudulent Practices Mobile Health Services Home Health Medical Transportation Healthcare Facilities Nursing Homes Cybersecurity Financial Results Software as a Service (SaaS) AI in Healthcare Long-term Investments Virtual Care Skilled Nursing Revenue Cycle Management Innovative Treatments Government Contracts Multispecialty Hospitals Data Analytics Urgent Care Cancer Treatment Logistics
Want to see what podcasts are saying about this topic? Search across 165K+ podcasts. Explore Radar
McKesson says the acquisition will boost its ability to run biomarker-driven trials to commercialize new cancer and specialty drugs
